NORWEGIANPHARMAFLUIDS AS

Operating

Agentur, engros, kjøp, salg, produksjon, forskning, utvikling, Laboratorium virksomhet, eksport, import, handel, industri, kjøp og salg av aksjer og andeler i andre selskaper og Fast eiendom og hva herved står i forbindelse.

Agenturvirksomhet, produksjon, eksport, import av produkter, farmasøytiske produkter, legemidler, forskning og utvikling, bioteknologi, laboratorievirksomhet, medisinsk tekniske produkter og utleie av tjenester og hva herved står i forbindelse.

Keywords

bicyclesmedicines

Organization

CEO: AO
Arnt Oddvar Skeimo1944
Chairman of the board: AJ
Aneeta Johnsen1958
Years since formation: 9 years; since Sep 15, 2016
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 600; 1 share class
Total number of shareholders: 9; persons

Financials

Annual total result 2024: -8,718; NOK
Total equity 2024: -26,762; NOK

Last update: Sep 9, 2025

Management

Management / administration

Name	Role	Shares
AO Arnt Oddvar Skeimo 1944	Managing Director/CEO	17.33 % directly

Board

Name	Role	Shares
AO Arnt Oddvar Skeimo 1944	Deputy Chair	17.33 % directly
AJ Aneeta Johnsen 1958	Chairman	10.33 % directly

Top 10 individual shareholders

Name	Role	Shares
AO Arnt Oddvar Skeimo 1944	Managing Director/CEO, Deputy Chair	17.33 % directly
FB Faiza Basharat 1959	-	10.33 % directly
PK Per Kristian Gråbø 1955	-	10.33 % directly
BO Bente Olavsrud 1960	-	10.33 % directly
DR Dennis Røller 1970	-	10.33 % directly
AJ Aneeta Johnsen 1958	Chairman	10.33 % directly
TA Tom Arli 1958	-	10.33 % directly
BA Bilal Ahmad Ata 1957	-	10.33 % directly
KO Karl Omar Kareem Skeimo 1997	-	10.33 % directly

Last update: Aug 7, 2025

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
AO Arnt Oddvar Skeimo 1944	Ordinary shares	104	17.33 %
BO Bente Olavsrud 1960	Ordinary shares	62	10.33 %
BA Bilal Ahmad Ata 1957	Ordinary shares	62	10.33 %
DR Dennis Røller 1970	Ordinary shares	62	10.33 %
FB Faiza Basharat 1959	Ordinary shares	62	10.33 %
KO Karl Omar Kareem Skeimo 1997	Ordinary shares	62	10.33 %
PK Per Kristian Gråbø 1955	Ordinary shares	62	10.33 %
AJ Aneeta Johnsen 1958	Ordinary shares	62	10.33 %
TA Tom Arli 1958	Ordinary shares	62	10.33 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Annual Total Result	-8,718	-5,390	-7,652	-6,418
Total assets	-6	20	-28	2,356
Total liabilities	26,755	18,063	23,765	18,505
Total equity	-26,762	-18,043	-23,793	-16,149

P&L

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Total operating costs	8,712	5,390	7,652	6,348
Operating result	-8,712	-5,390	-7,652	-6,348
Financial income/costs	-6	0	0	-70
Profit before tax	-8,718	-5,390	-7,652	-6,418
Total tax & extraordinary income/cost	0	0	0	0
Annual Total Result	-8,718	-5,390	-7,652	-6,418

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	0	0	0	0
Total current assets	-6	20	-28	2,356
Total assets	-6	20	-28	2,356
Short term debt	-5,883	-5,883	23,765	18,505
Long term debt	32,638	23,946	0	0
Total liabilities	26,755	18,063	23,765	18,505
Contributed capital	35,570	35,570	24,430	24,430
Retained earnings	-62,332	-53,613	-48,223	-40,579
Total equity	-26,762	-18,043	-23,793	-16,149
Total equity and liabilities	-6	20	-28	2,356

Classification

21st company classification

BETA

Scaleup

NORWEGIANPHARMAFLUIDS AS917 725 918